HealthManagement, IQ_2012_06_venus
Cutting Balloon versus Non-cutting Balloon for the Treatment of Venous Stenosis in the Fistulas of Hemodialyzed Patients (PREST)
Contact
Dr. Eric Picard, Centre Hospitalier Universitaire de Nîmes, FR
Date Opened
September 2011
Status
Not yet recruiting
Description
The main objective of this study is to evaluate and compare the primary patency rate at 12 months in a group of haemodialysis patients operated on by cutting balloon and in a group of haemodialysis patients operated by conventional balloon.
ClinicalTrials.gov Identifier: NCT01321866
Infrapopliteal Drug Eluting Angioplasty Versus Stenting (IDEAS-I)
Contact
Prof. Dimitrios Siablis, Patras University Hospital, GR
Date Opened
August 2011
Status
Recruiting
Description
The study's primary endpoint will be the 6-month angiographic binary restenosis rate. Secondary endpoints will include the immediate technical success, 6-month primary patency, target lesion revascularisation and limb salvage and complication rates.
ClinicalTrials.gov Identifier: NCT01517997
Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries (LEVANT 2)
Contact
Dr. Kenneth Rosenfield, Massachusetts General Hospital, US
Date Opened
July 2011
Status
Recruiting
Description
The purpose of this study is to demonstrate the superior efficacy and non-inferior safety of the Moxy Drug Coated Balloon by direct comparison to standard PTA for treatment of stenosis of the femoropopliteal arteries.
ClinicalTrials.gov Identifier: NCT01412541
Standard Balloon Angioplasty versus Angioplasty with a Paclitaxel-Eluting Balloon for Femoral Artery in-stent Restenosis (FAIR)
Contact
Dr. Hans Krankenberg, Medical Care Center Prof.
Mathey, Prof. Schofer, Ltd., DE
Date opened
January 2012
Status
Recruiting
Description
Comparison of recurrent-restenosis rates 6 months after angioplasty of in-stent restenoses or in-stent reocclusions in the superficial femoral artery (SFA) using either a standard balloon (Admiral Xtreme, Invatec) or a paclitaxel-eluting balloon (In.Pact™ Admiral, Invatec).
